Replies to post #204201 on Innovation Pharmaceuticals Inc (IPIX)

[DaubersUP]

What is your price estimate on this scenario;

BOM partner based on 70% prevention rates. Maybe 25mm upfront 200mm milestone to market, 30-40% royalties

Kevetrin proves exactly what BP wanted to see in the phase 2 OC trial. Great results and major tumor shrinkage

P shows 50% PASI 75 and 10% PASI 100 in the phase 2b

Don't even think about UC Eczema crohns absssi etc.....

I mean....I'd have to expect well over 20 dollars a share and on the Nasdaq. IMO.

Enough day dreaming. Onto the weekend.